Physician profile
Christopher P Epling
NPI 1649269101
$6,253.70
in general payments reported to CMS, 2019-2025
28 companies · $673 in 2025
The $673 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,126 · 2020: $1,050 · 2021: $471 · 2022: $575 · 2023: $624 · 2024: $735 · 2025: $673.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,031.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,031.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $2,052.78 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,429.58 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $703.47 | 2020-2025 | |
| Abbott Laboratories | $511.62 | 2019-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit, Assurity |
| Pfizer INC. | $267.50 | 2022-2025 | |
| Edwards Lifesciences Corporation | $212.10 | 2023-2024 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Medtronic, INC. | $168.87 | 2021-2023 | Onyx Frontier |
| Boston Scientific Corporation | $134.69 | 2021-2025 | Watchman Access System |
| Novo Nordisk INC | $100.46 | 2020-2025 | Ozempic, Wegovy, Rybelsus |
| Heartflow, INC. | $90.66 | 2021-2024 | |
| E.R. Squibb & Sons, L.L.C. | $80.82 | 2021-2024 | Eliquis, Camzyos |
| Shockwave Medical, INC | $72.49 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $55.20 | 2020-2025 | |
| Amgen INC. | $51.07 | 2022-2023 | Repatha |
| Janssen Pharmaceuticals, INC | $50.55 | 2019-2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $50.15 | 2025 | Inspire |
| Astrazeneca Pharmaceuticals Lp | $29.31 | 2023-2024 | Brilinta |
| Merck Sharp & Dohme LLC | $27.88 | 2024 | Verquvo |
| Acist Medical Systems, INC. | $24.00 | 2022 | |
| Cardiva Medical, INC. | $20.63 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Altathera Pharmaceuticals LLC | $19.71 | 2024 | Sotalol Hydrochloride |
| Regeneron Healthcare Solutions, INC. | $18.44 | 2024 | Evkeeza |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.54 | 2024 | Jardiance |
| Preventice Services, LLC | $16.16 | 2021 | |
| Terumo Medical Corporation | $15.40 | 2020 | |
| Cardiovascular Systems INC. | $12.00 | 2022 | |
| Esperion Therapeutics, INC. | $11.80 | 2021 | |
| Cvrx, INC. | $8.82 | 2024 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Epling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.